• 主题
高级搜索  >
历史搜索 清空历史
首页> 美国政府科技报告 >Uncarboxylated Osteocalcin and Gprc6a Axis Produce Intratumoral Androgens in Castration-Resistant Prostate Cancer.
【24h】

Uncarboxylated Osteocalcin and Gprc6a Axis Produce Intratumoral Androgens in Castration-Resistant Prostate Cancer.

机译：未羧化的骨钙蛋白和Gprc6a轴在去势抵抗的前列腺癌中产生肿瘤内雄激素。

获取原文
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Castrate resistant prostate cancer (CRPC) represents the final and lethal disease state in the progression of prostate cancer. CRPC patients often develop bone metastasis resulting in bone fractures and morbidity. Recently, tumor cells have been shown to activate androgen receptor signaling via multiple pathways, despite castrate levels of testosterone. One such adaptive mechanism is the intracrine production of androgens in the primary tumor and/or at metastatic sites by the activity of androgen biosynthetic enzymes. Recent study shows that Gprc6a/Osteocalcin axis regulates physiological androgen biosynthesis in testis. Since Osteocalcin is overexpressed in patients with bone metastasis and existence of intratumoral androgen synthesis in bone metastasis, we hypothesized that bone tumor expressed Osteocalcin can induce intratumoral androgen synthesis in bone metastasis. We show that in VCaP model system Gprc6a is expressed and overexpression of its ligand Osteocalcin in these cells leads to expression of androgen biosynthetic enzymes. This data suggest that prostate cancer bone tumors hijack Osteocalcin/Gprc6a axis for the production of intratumoral androgens via overexpression of certain androgen biosynthetic enzyme expression. Bone tumor expressed androgens promote disease progression via tumoral androgen production and androgen receptor activation.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号